Clinical Trial Update: A Phase I Study of SY-9453 in Patients With Advanced Solid Tumors [Phase 1]

View source ↗

Summary

An early Phase 1 trial of SY-9453 in patients with advanced or metastatic solid tumors with homozygous MTAP deletion is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Or Metastatic Solid Tumors with Homozygous Mtap Deletion

Drugs mentioned

• SY-9453

Snippet

Sponsor: Shouyao Holdings (Beijing) Co. LTD | Conditions: Advanced or Metastatic Solid Tumors With Homozygous MTAP Deletion | Phase 1 | Status: NOT_YET_RECRUITING